These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5123842)

  • 61. [Jet immunization with polyvalent vaccine against plague, tularemia, and anthrax].
    Loktev NA; Pilipenko VG; Basilova GI; Shchedrin VI; Lunina EA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):109-10. PubMed ID: 7445856
    [No Abstract]   [Full Text] [Related]  

  • 62. Tularemia vaccines.
    Putzova D; Senitkova I; Stulik J
    Folia Microbiol (Praha); 2016 Nov; 61(6):495-504. PubMed ID: 27194547
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [On long-term vaccinal immunity in those vaccinated with live tularemia vaccine].
    Uglovoĭ GP
    Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):87-9. PubMed ID: 5616812
    [No Abstract]   [Full Text] [Related]  

  • 64. [Evaluation of the vaccination against tularemia in the North-Bohemian Region].
    Vitková V; Richter J
    Bratisl Lek Listy; 1966 Aug; 46(3):162-6. PubMed ID: 5975154
    [No Abstract]   [Full Text] [Related]  

  • 65. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The properties of dry skin combined vaccine against plague, tularemia and brucellosis, prepared in one ampule].
    Pilipenko VG; Shchekina TA; Verkhovtseva GN
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Oct; 42(10):47-54. PubMed ID: 5871437
    [No Abstract]   [Full Text] [Related]  

  • 67. Tularemia immunization in early pregnancy.
    Albrecht RC; Cefalo RC; O'Brien WF
    Am J Obstet Gynecol; 1980 Dec; 138(8):1226-7. PubMed ID: 7446636
    [No Abstract]   [Full Text] [Related]  

  • 68. The effect of oil-emulsion vaccines on the occurrence of nonspecific plate agglutination reactions for Mycoplasma gallisepticum and M. synoviae.
    Glisson JR; Dawe JF; Kleven SH
    Avian Dis; 1984; 28(2):397-405. PubMed ID: 6331364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The effect of pre-existing immunity to one of the antigens of a combined vaccine against plague, tularemia and brucellosis on the immunizing properties of its other components. IV].
    Pilipenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):50-4. PubMed ID: 5662249
    [No Abstract]   [Full Text] [Related]  

  • 70. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 71. [Pronounced reaction after vaccination against tularemia].
    Koldoba LG; Rudenko MI
    Vrach Delo; 1969 May; 5():116-7. PubMed ID: 5368854
    [No Abstract]   [Full Text] [Related]  

  • 72. [Two cases of allergic reactions to bites by infected ticks from the family Rhipecephalus rossicus in subjects vaccinated against tularemia].
    BORODIN VP; SAMSONOVA AP; KOROLEVA AP
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Nov; 29(11):117-8. PubMed ID: 13626118
    [No Abstract]   [Full Text] [Related]  

  • 73. [Experimental trials of vaccination against tularemia].
    NELIS P; LAFONTAINE A; DE MAEYER-CLEEMPOEL ; MASSA H
    Rev Immunol Ther Antimicrob; 1952; 16(4-5):300-4. PubMed ID: 13014715
    [No Abstract]   [Full Text] [Related]  

  • 74. [Allergic reaction in men following vaccination with living yolk tularemia vaccine in cutaneous application].
    DIACHENKO SS; KHIZHINS'KA OP; BUIALO SG
    Mikrobiol Zh; 1953; 15(1):27-32. PubMed ID: 13132524
    [No Abstract]   [Full Text] [Related]  

  • 75. [Mass study of immunological effectiveness of vaccination against tularemia].
    SIL'CHENKO VS
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Apr; 28(4):34-7. PubMed ID: 13486900
    [No Abstract]   [Full Text] [Related]  

  • 76. Francisella tularensis LVS surface and membrane proteins as targets of effective post-exposure immunization for tularemia.
    Chandler JC; Sutherland MD; Harton MR; Molins CR; Anderson RV; Heaslip DG; Bosio CM; Belisle JT
    J Proteome Res; 2015 Feb; 14(2):664-75. PubMed ID: 25494920
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
    Jia Q; Bowen R; Dillon BJ; Masleša-Galić S; Chang BT; Kaidi AC; Horwitz MA
    Sci Rep; 2018 May; 8(1):7009. PubMed ID: 29725025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Conditions for the effectiveness of preventive immunization against tularemia].
    Sil'chenko VS
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jun; 44(6):88-93. PubMed ID: 5616834
    [No Abstract]   [Full Text] [Related]  

  • 79. [Studies on immunological reactivity of the organism following vaccination against tularemia in subjects with modified state of the central nervous system].
    MATVEETS LS; OLSUF'EV NG; IL'INSKII IuA; ZHRAIKOV NM; KERBIKOV OV
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Sep; 28(9):46-51. PubMed ID: 13531851
    [No Abstract]   [Full Text] [Related]  

  • 80. [THE APPLICATION OF ANTIBODY NEUTRALIZATION REACTIONS FOR THE RETROSPECTIVE DIAGNOSIS OF EPIZOOTICS OF TULAREMIA].
    SHIRIAEV DT; TOKAREV SA; SHEVCHENKO SF
    Zh Mikrobiol Epidemiol Immunobiol; 1964 May; 41():50-4. PubMed ID: 14231868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.